Latondra Newton
Known title: DirectorCIK: 0001983540
Associated companies
Transaction History
| PHIN | ▲ Buy | Grant | 17 | $0 | 9/18/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 13 | $0 | 6/23/2026 | View on chart |
| PHIN | ▲ Buy | Option Exercise | 3,367 | — | 5/21/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 21 | $0 | 3/14/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 12/13/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 18 | $0 | 9/13/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 20 | $0 | 6/14/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 3,261 | $0 | 5/9/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 90 | $0 | 3/15/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 114 | $0 | 12/15/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 125 | $0 | 9/22/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 8,142 | $0 | 7/18/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 4,749 | $0 | 7/18/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
UBS Lowers PHIN Target to $68, Keeps Neutral Rating
UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.
UBS Lowers PHIN Target to $68, Keeps Neutral Rating. UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.